• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar for Sept. 3-7, 2007

 

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Andrew von Eschenbach, Commissioner, Food and Drugs9/4/07Austin, TXN/ATexas Governor Rick Perry, Texas First Lady Anita Perry, and Guy Diedrich, Michael McKinney, Lou Ann McKinney, Bill Jones (Texas A&M)$3 billion cancer initiative
Andrew von Eschenbach, Commissioner, Food and Drugs9/4/07Austin, TXN/AGuy Diedrich, Elsa Murano (Texas A&M)Texas A&M's agriculture initiatives in China
Andrew von Eschenbach, Commissioner, Food and Drugs9/5/07Atlanta, GAJoseph Grogan Speech at DoD Prostate Cancer Research Program Investigators Meeting
Andrew von Eschenbach, Commissioner, Food and Drugs9/7/07Washington DCJanet Woodcock, John DyerMark McClellan, Kristina Hanson Lowell (The Brookings Institution), Richard Platt (Harvard) Janet Marchibroda (E Health Initiative) Sam Nussbaum (Wellpoint), Garry Neil (J &J) Amit Sachdev (Vertex) John Alam (Vertex), Glenn Gormley (Norvatis), Joel Kupersmith (Veterans Administration), Kevin Cameron (Web MD) Ron Krall (Glaxo Smith Kline), Arnold Chan (Ingenix)FDA postmarket surveillance implementation
John Dyer, Deputy Commissioner, Operations and Chief Operating OfficerN/AN/AN/AN/ANo significant meetings
Murray Lumpkin, Deputy Commissioner, International and Special Programs9/6/07Rockville, MDWalter BattsLadd Wiley (Akin Gump), Chris LeGrand (Constella Group)International issues
Randall Lutter, Deputy Commissioner, Policy9/3/07 through 9/7/07N/AN/AN/ANo significant meetings
Janet Woodcock, Deputy Commissioner and Chief Medical Officer9/4/07Rockville, MDN/AEllen Sigal, Jeff Allen (Friends of Cancer Research)Cancer program
Janet Woodcock, Deputy Commissioner and Chief Medical Officer9/6/07Washington, DCSheldon BradshawU.S. Congressman Henry Waxman, U.S. Congressman Frank Pallone, Kathleen Jaeger (Generic Pharmaceutical Association)FDA policy initiatives and implications for the generics industry
Janet Woodcock, Deputy Commissioner and Chief Medical Officer9/7/07Washington, DCLeonard SacksDavid Bowen (Senate HELP Committee), Frederick Rickles (George Washington University), Mark Boutin (National Health Council), Amrit Ray (Bristol-Myers-Squibb)Developing mechanisms for pharmacovigilance
Janet Woodcock, Deputy Commissioner and Chief Medical Officer9/9/07San Francisco, CAFelix Frueh, Norman StockbridgeRay Woosley (Critical Path Institute), Anthony Altar (FNIH)How the Critical Path is beginning to transform drug development and regulatory decision
Margaret Glavin, Associate Commissioner, Office of Regulatory Affairs9/3/07 through 9/7/07N/AN/AN/ANo significant meetings
Jesse Goodman, Director, Center for Biologics Evaluation and Research9/3/07 through 9/7/07N/AN/AN/ANo significant meetings
Steven Galson, Director, Center for Drug Evaluation and Research9/4/07Washington, DCN/ABiotechnology Industry Organization (BIO) Board MembersBIO Board dinner meeting
Steven Galson, Director, Center for Drug Evaluation and Research9/7/07Silver Spring , MDGary Buehler, Dena Hixon, Dale Connor, Robert Temple, Russell Katz, Anne HenigMembers of Epilepsy FoundationMeeting with Epilepsy Foundation
Daniel Schultz, Director, Center for Devices and Radiological Health9/3/07 through 9/7/07N/AN/AN/ANo significant meetings
Robert Brackett, Director, Center for Food Safety and Applied Nutrition9/6/07College Park, MDJoseph Baca, Nega Beru, Michael Rogers, Don Kraemer, Amy Lando, Kelly Randolph, Danella Tavern, Judy Lee, Jennifer Thomas   Bruce Becker (GMA/SAFE) GMA/SAFE presentation
Stephen Sundlof, Director, Center for Veterinary Medicine9/3/07 through 9/7/07Breckenridge, COMerton Smith, Steve Vaughn, Steven Brynes, Kevin Greenlees, Lynn Friedlander, Valerie Reeves, Philip KijakCodex Alimentarius Commission MembersMaximum residue limits of veterinary drug residues in foods
William Slikker, Director, National Center for Toxicological Research9/4/07Little Rock, ARCheng Wang, Rick Beger, Merle Paule, and Xuan ZhangStaff members of the University of Arkansas for Medical Sciences (UAMS)UAMS Seminar,  Biofunctional Imaging & Image Guided Therapies for Neuroscience
William Slikker, Director, National Center for Toxicological Research9/5/07Little Rock, ARBeverly Lyn-Cook and George HammonsProfessionals, educators, and citizens from Arkansas and other statesConference "Energizing & Employing Arkansans for a Brighter Economic Future," hosted by the Arkansas STEM Coalition
William Slikker, Director, National Center for Toxicological Research (NCTR)9/5/07Little Rock, ARJames Fuscoe, Weida Tong, and Beverly Lyn-CookGail Cassell (Eli Lilly and Company), Arthur Norris (Consultant to The Alliance of Jefferson County, AR)Overview of NCTR programs for a better understanding of NCTR's research capabilities
William Slikker, Director, National Center for Toxicological Research9/6/07Little Rock, ARWilliam TollesonStaff members of the University of Arkansas for Medical Sciences (UAMS)UAMS Head and Neck Cancer Interest Group Meeting
Sheldon Bradshaw, Chief Counsel

9/3/07 through 9/7/07

 

N/AN/AN/ANo significant meetings